Ray Dalio
AKRO

Ray Dalio’s Akero Therapeutics AKRO Stock Holding History

Ray Dalio’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,256
Closed -$202K – 1047
2025
Q3 		$202K Buy
+4,256
New +$206K ﹤0.01% 1008

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Ray Dalio's AKRO Position: Q4 2025 in Review

Ray Dalio sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 4,256 shares — an estimated $202K sold.

Ray Dalio first reported a position in AKRO in Q3 2025 and held it in 1 quarter. The position peaked at $202K in Q3 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • Ray Dalio reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Ray Dalio sold 4,256 Akero Therapeutics shares in Q4 2025, an estimated $202K.
  • Ray Dalio first reported a position in Akero Therapeutics in Q3 2025 and held it in 1 quarter.
  • Ray Dalio's Akero Therapeutics position peaked at $202K in Q3 2025.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Bridgewater Associates's 13F filing for Q4 2025, filed 13 Feb 2026.